| Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients I Bairati, F Meyer, M Gélinas, A Fortin, A Nabid, F Brochet, JP Mercier, ... Journal of clinical oncology 23 (24), 5805-5813, 2005 | 328 | 2005 |
| Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study E Vigneault, J Pouliot, J Laverdière, J Roy, M Dorion International Journal of Radiation Oncology* Biology* Physics 37 (1), 205-212, 1997 | 304 | 1997 |
| A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients I Bairati, F Meyer, M Gélinas, A Fortin, A Nabid, F Brochet, JP Mercier, ... Journal of the National Cancer Institute 97 (7), 481-488, 2005 | 292 | 2005 |
| Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy B Pickett, E Vigneault, J Kurhanewicz, L Verhey, M Roach International Journal of Radiation Oncology* Biology* Physics 44 (4), 921-929, 1999 | 271 | 1999 |
| Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers JF Aubry, L Beaulieu, LM Girouard, S Aubin, D Tremblay, J Laverdière, ... International Journal of Radiation Oncology* Biology* Physics 60 (1), 30-39, 2004 | 190 | 2004 |
| Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiotherapy for Adenocarcinoma of the Prostate: Preliminary Results of RTOG 0321 I Hsu, K Bae, K Shinohara, J Pouliot, J Purdy, G Ibbott, J Speight, ... International Journal of Radiation Oncology* Biology* Physics 72 (1), S133, 2008 | 149 | 2008 |
| Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321 IC Hsu, K Bae, K Shinohara, J Pouliot, J Purdy, G Ibbott, J Speight, ... International Journal of Radiation Oncology* Biology* Physics 78 (3), 751-758, 2010 | 148 | 2010 |
| Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy P Xia, B Pickett, E Vigneault, LJ Verhey, M Roach International Journal of Radiation Oncology* Biology* Physics 51 (1), 244-254, 2001 | 145 | 2001 |
| Intermittent vs continuous androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis S Magnan, R Zarychanski, L Pilote, L Bernier, M Shemilt, E Vigneault, ... JAMA oncology 1 (9), 1261-1269, 2015 | 144 | 2015 |
| Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer C Fakhry, Q Zhang, PF Nguyen-Tân, DI Rosenthal, RS Weber, L Lambert, ... Journal of Clinical Oncology, JCO. 2016.72. 0748, 2017 | 137 | 2017 |
| The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC) F Saad, KN Chi, A Finelli, SJ Hotte, J Izawa, A Kapoor, W Kassouf, ... Canadian Urological Association Journal 9 (3-4), 90, 2015 | 135 | 2015 |
| 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multi-institutional review JB Fiveash, G Hanks, M Roach, S Wang, E Vigneault, PW McLaughlin, ... International Journal of Radiation Oncology* Biology* Physics 47 (2), 335-342, 2000 | 124 | 2000 |
| Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck A Fortin, CS Wang, É Vigneault International Journal of Radiation Oncology* Biology* Physics 74 (4), 1062-1069, 2009 | 120 | 2009 |
| Treatment options for localized prostate cancer M Keyes, J Crook, G Morton, E Vigneault, N Usmani, WJ Morris Canadian Family Physician 59 (12), 1269-1274, 2013 | 117 | 2013 |
| An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome F Bachand, AG Martin, L Beaulieu, F Harel, É Vigneault International Journal of Radiation Oncology* Biology* Physics 73 (3), 679-684, 2009 | 102 | 2009 |
| Is single fraction 15Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer? G Morton, A Loblaw, P Cheung, E Szumacher, M Chahal, C Danjoux, ... Radiotherapy and Oncology 100 (3), 463-467, 2011 | 99 | 2011 |
| Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer HKG Shu, TT Lee, E Vigneault, P Xia, B Pickett, TL Phillips, M Roach Urology 57 (1), 102-107, 2001 | 99 | 2001 |
| Psychological functioning associated with prostate cancer: cross-sectional comparison of patients treated with radiotherapy, brachytherapy, or surgery S Hervouet, J Savard, S Simard, H Ivers, J Laverdière, É Vigneault, ... Journal of pain and symptom management 30 (5), 474-484, 2005 | 96 | 2005 |
| Postimplant dosimetry using a Monte Carlo dose calculation engine: a new clinical standard JF Carrier, M D’Amours, F Verhaegen, B Reniers, AG Martin, E Vigneault, ... International Journal of Radiation Oncology* Biology* Physics 68 (4), 1190-1198, 2007 | 93 | 2007 |
| Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate B Lachance, D Béliveau-Nadeau, É Lessard, M CHRetien, ICJ Hsu, ... International Journal of Radiation Oncology* Biology* Physics 54 (1), 86-100, 2002 | 87 | 2002 |
